Form 8-K - Current report:
SEC Accession No. 0001104659-25-096051
Filing Date
2025-10-02
Accepted
2025-10-02 16:01:35
Documents
12
Period of Report
2025-09-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2527853d1_8k.htm   iXBRL 8-K 22376
  Complete submission text file 0001104659-25-096051.txt   186850

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA hypd-20250930.xsd EX-101.SCH 3026
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE hypd-20250930_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hypd-20250930_pre.xml EX-101.PRE 22366
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2527853d1_8k_htm.xml XML 3690
Mailing Address 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017 833-393-6684
HYPERION DEFI, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 251368827
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)